id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0326-0348,FDA,FDA-2008-N-0326,"Reference 12 - New England Journal of Medicine, Mechanism of Disease The New B-Lactamases  re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2012-07-04T04:00:00Z,2012,7,,,2012-07-04T16:54:14Z,,0,0,090000648064e653
FDA-2008-N-0326-0346,FDA,FDA-2008-N-0326,References (Pfizer - Comment) re FDA-2008-N-0326-0165 - Background,Supporting & Related Material,Background Material,2012-07-04T04:00:00Z,2012,7,,,2012-07-04T15:15:48Z,,0,0,0900006480788190
FDA-2008-N-0326-0345,FDA,FDA-2008-N-0326,Office of the Executive Secretariat (OES) Response to Council of State Territorial Epidemiologists (CSTE) - Letter re FDA-2008-N-0326-0333,Other,Letter(s),2012-07-03T04:00:00Z,2012,7,,,2012-07-04T15:49:08Z,,0,0,09000064810121c1
FDA-2008-N-0326-0338,FDA,FDA-2008-N-0326,See FDA-2008-N-0326-0302,Supporting & Related Material,Reference (external attachments),2012-04-18T04:00:00Z,2012,4,,,2012-04-24T21:16:10Z,,0,0,0900006480fd8b41
FDA-2008-N-0326-0333,FDA,FDA-2008-N-0326,See FDA-2008-N-0326-0344,Supporting & Related Material,Background Material,2012-03-29T04:00:00Z,2012,3,,,2012-07-04T15:53:44Z,,0,0,0900006480fe3bfb
FDA-2008-N-0326-0269,FDA,FDA-2008-N-0326,American Academy of Pediatrics re FDA-2008-N-0326-0268,Supporting & Related Material,Reference (external attachments),2012-03-06T05:00:00Z,2012,3,,,2012-03-06T16:28:40Z,,0,0,0900006480fcb04e
FDA-2008-N-0326-0283,FDA,FDA-2008-N-0326,"The Veterinary Pharmacy (TVP), Inc. - Request for Extension",Other,Request for Extension,2012-03-06T05:00:00Z,2012,3,2012-01-06T05:00:00Z,2012-03-07T04:59:59Z,2012-03-08T20:13:45Z,,0,0,0900006480fcf456
FDA-2008-N-0326-0177,FDA,FDA-2008-N-0326,New Animal Drugs; Orders of Prohibition: Cephalosporin Drugs; Extralabel Animal Drug Use,Rule,Final Rule,2012-01-06T05:00:00Z,2012,1,2012-01-06T05:00:00Z,2012-03-07T04:59:59Z,2012-07-05T02:01:56Z,2012-00035,0,0,0900006480f8ecbc
FDA-2008-N-0326-0176,FDA,FDA-2008-N-0326,New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Revocation of Order of Prohibition; Withdrawal,Rule,NWL-Notice of Withdrawl,2008-11-26T05:00:00Z,2008,11,2008-11-26T05:00:00Z,,2008-12-20T16:26:21Z,E8-28093,0,0,09000064807c1087
FDA-2008-N-0326-0172,FDA,FDA-2008-N-0326,"Attachment 2 - Executive Summary and Reference List 1-16, 8-41 (Pfizer - Comment) re FDA-2008-N-0326-0165 and FDA-2008-N-0326-0346",Supporting & Related Material,Background Material,2008-11-04T05:00:00Z,2008,11,,,2012-07-04T15:30:52Z,,0,0,09000064807940aa
FDA-2008-N-0326-0173,FDA,FDA-2008-N-0326,See FDA-2008-N-0326-0116 (American College of Poultry Veterinarians - Comment),Supporting & Related Material,Background Material,2008-11-04T05:00:00Z,2008,11,,,2012-07-04T17:00:54Z,,0,0,0900006480794057
FDA-2008-N-0326-0051,FDA,FDA-2008-N-0326,Sample Write-In Campaign 1 [Multiple Submitters=6] - Form Letter Comment,Other,FL-Form Letter,2008-08-18T04:00:00Z,2008,8,2008-08-18T04:00:00Z,,2012-03-07T17:19:37Z,,0,0,09000064806caf24
FDA-2008-N-0326-0049,FDA,FDA-2008-N-0326,New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition; Extension of Comment Period; Delay of Effective Date of Final Rule,Rule,Delay of Effective Date,2008-08-18T04:00:00Z,2008,8,2008-08-18T04:00:00Z,2008-11-04T04:59:59Z,2012-01-27T23:43:15Z,E8-18967,0,0,09000064806ca625
FDA-2008-N-0326-0036,FDA,FDA-2008-N-0326,American Association of Small Ruminant Practitioner - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-08-10T04:00:00Z,2008,8,2008-08-10T04:00:00Z,,2008-08-10T22:23:19Z,,0,0,09000064806b7ab7
FDA-2008-N-0326-0029,FDA,FDA-2008-N-0326,American Association of Bovine Practitioners - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-08-05T04:00:00Z,2008,8,2008-08-05T04:00:00Z,,2013-07-27T22:19:07Z,,0,0,090000648068cb7f
FDA-2008-N-0326-0025,FDA,FDA-2008-N-0326,American Association of Bovine Practitioners - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-07-22T04:00:00Z,2008,7,2008-07-22T04:00:00Z,,2013-08-11T04:27:03Z,,0,0,090000648068d52e
FDA-2008-N-0326-0026,FDA,FDA-2008-N-0326,"Pfizer, Inc. - Request for Extension Comment Due Date",Other,EXT-Request for Extension Comment Due Date,2008-07-22T04:00:00Z,2008,7,2008-07-22T04:00:00Z,,2013-07-27T22:19:18Z,,0,0,090000648068d596
FDA-2008-N-0326-0024,FDA,FDA-2008-N-0326,Animal Health Institute - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-07-22T04:00:00Z,2008,7,2008-07-22T04:00:00Z,,2013-07-27T22:18:59Z,,0,0,0900006480685084
FDA-2008-N-0326-0023,FDA,FDA-2008-N-0326,American Veterinary Medical Association - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-07-18T04:00:00Z,2008,7,2008-07-18T04:00:00Z,,2013-07-27T22:18:53Z,,0,0,090000648067ffa0
FDA-2008-N-0326-0001,FDA,FDA-2008-N-0326,New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition,Rule,NFR-Notice of Final Rule,2008-07-03T04:00:00Z,2008,7,2008-07-03T04:00:00Z,2008-09-04T03:59:59Z,2012-07-05T02:02:01Z,E8-15052,0,0,0900006480653961
FDA-2008-N-0326-0008,FDA,FDA-2008-N-0326,"Reference 7 - CDC, National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2004 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:56:03Z,,0,0,090000648064e468
FDA-2008-N-0326-0011,FDA,FDA-2008-N-0326,"Reference 10 - Clinical & Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:56:46Z,,0,0,090000648064e62b
FDA-2008-N-0326-0004,FDA,FDA-2008-N-0326,"Reference 3 - B-Lactam Resistance & B-lactamases in Bacteria of Animal Origin re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:55:08Z,,0,0,090000648064e439
FDA-2008-N-0326-0005,FDA,FDA-2008-N-0326,"Reference 4 - EARSS Annual Report 2005 Pages 1-147 2006 Bilthoven, The Netherlands, European Antimicrobial Resistance Surveillance System re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:55:22Z,,0,0,090000648064e441
FDA-2008-N-0326-0010,FDA,FDA-2008-N-0326,"Reference 9 - American Society for Microbiology, B-Lactamaces in Laboratory & Clinical Resistance re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:56:34Z,,0,0,090000648064e61f
FDA-2008-N-0326-0014,FDA,FDA-2008-N-0326,"List of References re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:57:28Z,,0,0,0900006480654597
FDA-2008-N-0326-0009,FDA,FDA-2008-N-0326,"Reference 8 - American Society for Microbiology, DNA Sequence Analysis of Regions Surrounding blacmy-2 from Multiple Salmonella Plasmid Backbones re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:56:13Z,,0,0,090000648064e603
FDA-2008-N-0326-0002,FDA,FDA-2008-N-0326,"Reference 1 - Williams et al Antibiotics in Laboratory Medicine re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:54:43Z,,0,0,090000648064e32d
FDA-2008-N-0326-0007,FDA,FDA-2008-N-0326,"Reference 6 - CDC Enteric Disease Branch, Animal-to-man Transmission of Antimicrobial-resistant Salmonella: Investigations of United States Outbreaks, 1971-1983 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:55:50Z,,0,0,090000648064e45d
FDA-2008-N-0326-0003,FDA,FDA-2008-N-0326,"Reference 2 - US Food & Drug Administration, Maxipime (Cefepime Hydrochloride) for Injection, Powder, For Solution (Bristol-Myers Squibb) re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:54:56Z,,0,0,090000648064e42a
FDA-2008-N-0326-0006,FDA,FDA-2008-N-0326,"Reference 5 - USDA/ARS National Antimicrobial Resistance Montoring System, Veterinary Isolates Data re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:55:34Z,,0,0,090000648064e44b
FDA-2008-N-0326-0012,FDA,FDA-2008-N-0326,"Reference 11 - J. of Antimicrobial Chemotherapy, CTX-M: Changing the Face of ESBLs In Europe re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:56:59Z,,0,0,090000648064e63a
FDA-2008-N-0326-0013,FDA,FDA-2008-N-0326,"Reference 13 - Summary of Data from Hatchery Inspections Conducted September-October, 2001 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background",Supporting & Related Material,Background Material,2008-07-03T04:00:00Z,2008,7,,,2012-07-04T16:57:14Z,,0,0,090000648064e666